Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendationMatthias Gückenberger, Piet Ost, Yolande Lievens et al.|The Lancet Oncology|2020Cited by 1.1k
Prevalence and Characteristics of Nutritional Depletion in Patients with Stable COPD Eligible for Pulmonary RehabilitationAnnemie M.W.J. Schols, Emiel F.�M. Wouters, R. Mostert et al.|American Review of Respiratory Disease|1993Cited by 725
Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment OutcomeJules L. Derks, Anne‐Marie C. Dingemans|Clinical Cancer Research|2017Cited by 220
Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?Joline S.W. Lind, Egbert F. Smit, Martijn R. Meijerink et al.|European Radiology|2010Cited by 84
Clinical-Pathologic Challenges in the Classification of Pulmonary Neuroendocrine Neoplasms and Targets on the Horizon for Future Clinical PracticeJules L. Derks, Anne‐Marie C. Dingemans|Journal of Thoracic Oncology|2021Cited by 50